Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
New data on mechanisms of acquired resistance after 1st-line Tagrisso in NSCLC support initiation of ORCHARD trial to explore post-progression treatment options
-
CHMP issues a positive opinion for Bevespi Aerosphere for the treatment of chronic obstructive pulmonary disease
-
US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer
-
AstraZeneca presents advances in improving treatment options for ovarian and lung cancer patients at ESMO 2018 Congress
-
Imfinzi is the first immunotherapy to demonstrate significant overall survival benefit in unresectable, Stage III lung cancer
-
Bydureon receives positive EU CHMP opinion for EXSCEL cardiovascular outcomes data
-
European Commission approves Imfinzi for locally-advanced, unresectable NSCLC
-
Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes
-
AstraZeneca presents further data showing the interconnectivity between cardiovascular and renal risks in diabetes at EASD 2018
-
Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
